Nature Communications (Jun 2017)

Correction: Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy

  • Niclas E. Bengtsson,
  • John K. Hall,
  • Guy L. Odom,
  • Michael P. Phelps,
  • Colin R. Andrus,
  • R. David Hawkins,
  • Stephen D. Hauschka,
  • Joel R. Chamberlain,
  • Jeffrey S. Chamberlain

DOI
https://doi.org/10.1038/ncomms16007
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 1

Abstract

Read online

Nature Communications 8: Article number: 14454 (2017); Published: 14 February 2017; Updated: 23 June 2017 This Article contains an error in Fig. 4, for which we apologize. In panel a, the image reporting dystrophin labelling following SaCas9Δ5253 treatment was inadvertently duplicated from the corresponding image following SpCas9/Δ5253 treatment.